Department of Surgical Sciences - Radiology Unit, A.O.U. Città della Salute e della Scienza di Torino, Via Genova 3, 10126, Turin, Italy.
Department of Surgical Sciences - Radiology Unit, University of Torino - A.O.U. Città della Salute e della Scienza di Torino, Via Genova 3, 10126, Turin, Italy.
Eur Radiol. 2021 Sep;31(9):6578-6588. doi: 10.1007/s00330-021-07792-2. Epub 2021 Mar 18.
To investigate the predictive value of four-phase contrast-enhanced CT (CECT) for early complete response (CR) to drug-eluting-bead transarterial chemoembolization (DEB-TACE), with a particular focus on the quantitatively assessed wash-in and wash-out.
A retrospective analysis of preprocedural CECTs was performed for 129 HCC nodules consecutively subjected to DEB-TACE as first-line therapy. Lesion size, location, and margins were recorded. For the quantitative analysis, the following parameters were computed: contrast enhancement ratio (CER) and lesion-to-liver contrast ratio (LLC) as estimates of wash-in; absolute and relative wash-out (WO and WO) and delayed percentage attenuation ratio (DPAR) as estimates of wash-out. The early radiological response of each lesion was assessed by the mRECIST criteria and dichotomized in CR versus others (partial response, stable disease, and progressive disease).
All quantitatively assessed wash-out variables had significantly higher rates for CR lesions (WO p = 0.01, WO p = 0.01, and DPAR p = 0.00002). However, only DPAR demonstrated an acceptable discriminating ability, quantified by AUC = 0.80 (95% CI0.73-0.88). In particular, nodules with DPAR ≥ 120 showed an odds ratio of 3.3(1.5-7.2) for CR (p = 0.0026). When accompanied by smooth lesion margins, DPAR ≥ 120 lesions showed a 78% CR rate at first follow-up imaging. No significative association with CR was found for quantitative wash-in estimates (CER and LLC).
Based on preprocedural CECT, the quantitative assessment of HCC wash-out is useful in predicting early CR after DEB-TACE. Among the different formulas for wash-out quantification, DPAR has the best discriminating ability. When associated, DPAR ≥ 120 and smooth lesion margins are related to relatively high CR rates.
• A high wash-out rate, quantitatively assessed during preprocedural four-phase contrast-enhanced CT (CECT), is a favorable predictor for early radiological complete response of HCC to drug-eluting-bead chemoembolization (DEB-TACE). • The arterial phase of CECT shows great dispersion of attenuation values among different lesions, even when a standardized protocol is used, limiting its usefulness for quantitative analyses. • Among the different formulas used to quantify the wash-out rate (absolute wash-out, relative wash-out, and delayed percentage attenuation ratio), the latter (DPAR), based only on the delayed phase, is the most predictive (AUC = 0.80), showing a significant association with complete response for values above 120.
探讨四期对比增强 CT(CECT)对载药微球动脉化疗栓塞术(DEB-TACE)早期完全缓解(CR)的预测价值,尤其关注定量评估的强化方式和廓清方式。
回顾性分析了 129 个连续接受 DEB-TACE 作为一线治疗的 HCC 结节的术前 CECT。记录病变大小、位置和边界。进行定量分析,计算以下参数:对比增强比(CER)和病变与肝脏对比比(LLC),作为强化方式的估计值;绝对廓清(WO)和相对廓清(WO)以及延迟百分比衰减比(DPAR),作为廓清方式的估计值。根据 mRECIST 标准评估每个病变的早期影像学反应,并将其分为 CR 与其他反应(部分缓解、稳定疾病和进展性疾病)。
所有定量评估廓清变量在 CR 病变中的发生率均显著更高(WO,p=0.01;WO,p=0.01;DPAR,p=0.00002)。然而,只有 DPAR 具有可接受的鉴别能力,AUC=0.80(95%CI 0.73-0.88)。特别是,DPAR≥120 的结节发生 CR 的优势比为 3.3(1.5-7.2)(p=0.0026)。当病变边界光滑时,首次随访时 DPAR≥120 的病变 CR 率为 78%。定量强化估计值(CER 和 LLC)与 CR 无显著相关性。
基于术前 CECT,HCC 廓清的定量评估对预测 DEB-TACE 后早期 CR 有帮助。在不同的廓清定量公式中,DPAR 具有最佳的鉴别能力。当与 DPAR≥120 和病变边界光滑同时存在时,与相对较高的 CR 率相关。
在术前四期 CECT 中,强化廓清率高是 HCC 对 DEB-TACE 早期影像学完全缓解的有利预测因素。
即使使用标准化方案,CECT 的动脉期也显示出不同病变之间衰减值的很大差异,限制了其在定量分析中的应用。
在用于量化廓清率的不同公式中(绝对廓清、相对廓清和延迟百分比衰减比),仅基于延迟期的 DPAR 是最具预测性的(AUC=0.80),对于超过 120 的值与完全缓解有显著关联。